This is not the most recent version of the article. View current version (13 OCT 2014)

Intervention Protocol

Anticholinesterase treatment for myasthenia gravis

  1. Man Mohan Mehndiratta1,*,
  2. Thierry Kuntzer2,
  3. Sanjay Pandey3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 23 JAN 2008

DOI: 10.1002/14651858.CD006986


How to Cite

Mehndiratta MM, Kuntzer T, Pandey S. Anticholinesterase treatment for myasthenia gravis (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006986. DOI: 10.1002/14651858.CD006986.

Author Information

  1. 1

    G.B. Pant Hospital, Department of Neurology, New Delhi, India

  2. 2

    CHU Vaudois and University of Lausanne, Nerve-Muscle Unit, Service of Neurology, Lausanne, Switzerland

  3. 3

    G.B. Pant Hospital , Department of Neurology, New Delhi, India

*Man Mohan Mehndiratta, Department of Neurology, G.B. Pant Hospital, #502, Academic Block, New Delhi, 110002, India. mmehndi@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 JAN 2008

SEARCH

This is not the most recent version of the article. View current version (13 OCT 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To review the evidence from randomised trials concerning the benefits and harms from AChE inhibitor treatment for generalised myasthenia gravis.